Jidong Jia Selected Research

Jidong Jia Research Topics

Disease

67	Fibrosis (Cirrhosis) 04/2024 - 12/2002
59	Chronic Hepatitis B 12/2023 - 02/2008
37	Infections 04/2024 - 11/2009
33	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 12/2002
20	Hepatitis B 04/2024 - 05/2013
19	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 03/2016
17	Liver Diseases (Liver Disease) 11/2022 - 02/2008
8	Disease Progression 01/2023 - 02/2013
8	Chronic Hepatitis C 09/2021 - 10/2015
7	Inflammation (Inflammations) 06/2022 - 08/2015
6	Hepatitis 02/2024 - 01/2019
6	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2024 - 11/2016
5	Necrosis 01/2024 - 03/2011
5	Hepatitis C 12/2023 - 04/2011
5	Ascites 12/2023 - 01/2019
5	Chemical and Drug Induced Liver Injury 11/2023 - 02/2020
5	Liver Neoplasms (Liver Cancer) 10/2023 - 01/2021
5	Virus Diseases (Viral Diseases) 09/2021 - 10/2016
4	Iron Overload 03/2024 - 01/2021
4	Hemorrhage 12/2023 - 11/2021
4	Non-alcoholic Fatty Liver Disease 10/2021 - 12/2018
4	Neoplasms (Cancer) 01/2021 - 05/2015
3	Autoimmune Hepatitis 01/2024 - 01/2019
3	Portal Hypertension 12/2022 - 06/2010
3	Body Weight (Weight, Body) 11/2020 - 09/2019
2	End Stage Liver Disease 12/2022 - 11/2019
2	Biliary Atresia 06/2022 - 01/2022
2	Respiratory Tract Infections (Respiratory Tract Infection) 03/2022 - 01/2020
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 01/2022
2	Liver Failure 01/2022 - 01/2021
2	Fatty Liver 10/2021 - 12/2018
2	Viremia 06/2021 - 10/2020
2	Hyperbilirubinemia 01/2020 - 11/2018
2	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 01/2020 - 11/2018
2	Hemochromatosis (Bronze Diabetes) 01/2019 - 10/2018
2	Pruritus (Itching) 11/2016 - 10/2002

Drug/Important Bio-Agent (IBA)

42	Antiviral Agents (Antivirals)IBA 04/2024 - 02/2008
20	Hepatitis B e AntigensIBA 10/2022 - 02/2008
15	entecavir FDA Link 08/2023 - 12/2009
15	InterferonsIBA 12/2021 - 01/2011
13	CollagenIBA 10/2023 - 03/2011
12	Proteins (Proteins, Gene)FDA Link 03/2024 - 06/2010
12	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 01/2011
11	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2024 - 01/2011
11	Alanine Transaminase (SGPT)IBA 10/2023 - 12/2009
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 05/2013
7	NucleosidesIBA 12/2023 - 12/2009
7	NucleotidesIBA 12/2020 - 12/2009
7	Telbivudine FDA Link 03/2018 - 02/2008
6	SofosbuvirIBA 12/2023 - 01/2019
6	BilirubinIBA 12/2022 - 05/2018
6	Ribavirin (Virazole)FDA LinkGeneric 09/2019 - 04/2011
6	Lamivudine (Epivir)FDA Link 01/2019 - 02/2008
5	nasIBA 10/2022 - 01/2016
5	Tenofovir (Viread)FDA Link 03/2022 - 01/2019
5	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2014
5	TabletsIBA 01/2020 - 11/2016
5	AntigensIBA 01/2020 - 05/2015
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 08/2009
3	IronIBA 03/2024 - 01/2021
3	Immunoglobulin G (IgG)IBA 01/2024 - 08/2015
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2024 - 09/2018
3	LigandsIBA 01/2024 - 07/2020
3	AlbuminsIBA 12/2022 - 01/2018
3	CytokinesIBA 11/2021 - 08/2009
3	Collagen Type I (Type I Collagen)IBA 10/2021 - 09/2012
3	EnzymesIBA 10/2021 - 05/2019
3	Hydroxyproline (4 Hydroxyproline)IBA 10/2021 - 03/2011
3	Adenosine Triphosphate (ATP)IBA 12/2020 - 11/2018
3	ElastinIBA 01/2020 - 04/2018
3	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2019 - 05/2013
3	Ritonavir (Norvir)FDA Link 09/2019 - 05/2018
3	adefovirIBA 01/2019 - 12/2009
2	Transferrin (beta 2 Transferrin)IBA 03/2024 - 01/2019
2	Transaminases (Aminotransferases)IBA 01/2024 - 06/2022
2	GlucocorticoidsIBA 01/2024 - 01/2022
2	Complement System Proteins (Complement)IBA 08/2023 - 08/2009
2	AntibodiesIBA 11/2022 - 07/2020
2	Alkaline PhosphataseIBA 11/2022 - 10/2002
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 11/2022 - 10/2002
2	AutoantibodiesIBA 11/2022 - 05/2015
2	Multidrug Resistance-Associated Protein 2IBA 01/2020 - 11/2018
2	Interferon-alpha (Interferon Alfa)IBA 01/2020 - 11/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2019
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2020 - 04/2018
2	lipoarabinomannan (LAM)IBA 01/2020 - 01/2019
2	danoprevirIBA 09/2019 - 09/2019
2	Small Interfering RNA (siRNA)IBA 04/2018 - 05/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2018 - 03/2014
2	ThymosinIBA 01/2018 - 01/2015
2	CarbonIBA 08/2017 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 12/2002
2	Immunoglobulins (Immunoglobulin)IBA 05/2013 - 09/2012
2	Tissue Inhibitor of Metalloproteinase-1IBA 05/2013 - 11/2009
2	Messenger RNA (mRNA)IBA 06/2010 - 12/2002

Therapy/Procedure

55	Therapeutics 04/2024 - 02/2008
15	Liver Transplantation 12/2023 - 05/2013
3	Aftercare (After-Treatment) 03/2022 - 05/2017
3	Ligation 07/2020 - 03/2011
2	Secondary Prevention 04/2022 - 12/2021